Federal
Fair Prescription Drug Prices for Americans Act
Source: Congress.gov ·
737 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
II
118TH CONGRESS
1ST SESSION
S. 1218
To require that the retail list price for certain prescription drugs and biologi-
cal products may not exceed the average retail list price for the drug
or biological product among certain nations.
IN THE SENATE OF THE UNITED STATES
APRIL 19, 2023
Mr. HAWLEY introduced the following bill; which was read twice and referred
to the Committee on Health, Education, Labor, and Pensions
A BILL
To require that the retail list price for certain prescription
drugs and biological products may not exceed the average
retail list price for the drug or biological product among
certain nations.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Fair Prescription Drug
4
Prices for Americans Act’’.
5
VerDate Sep 11 2014
22:45 Apr 21, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\S1218.IS
S1218
kjohnson on DSK79L0C42PROD with BILLS
2
•S 1218 IS
SEC. 2. INTERNATIONAL REFERENCE PRICING FOR PRE-
1
SCRIPTION DRUGS AND BIOLOGICAL PROD-
2
UCTS.
3
(a) DEFINITIONS.—In this section:
4
(1) BIOLOGICAL PRODUCT.—The term ‘‘biologi-
5
cal product’’ means a biological product licensed
6
under subsection (a) or (k) of section 351 of the
7
Public Health Service Act (42 U.S.C. 262).
8
(2) DRUG.—The term ‘‘drug’’ means a drug ap-
9
proved under subsection (c) or (j) of section 505 of
10
the Federal Food, Drug, and Cosmetic Act (21
11
U.S.C. 355).
12
(3) SECRETARY.—The term ‘‘Secretary’’ means
13
the Secretary of Health and Human Services.
14
(b) CAP ON RETAIL LIST PRICE OF PRESCRIPTION
15
DRUGS
AND BIOLOGICAL PRODUCTS.—The retail list
16
price in the United States for a drug or a biological prod-
17
uct may not exceed the average retail list price for the
18
drug or biological product among Canada, France, Ger-
19
many, Italy, Japan, and the United Kingdom, as cal-
20
culated under subsection (c).
21
(c) CALCULATION
OF
AVERAGE
RETAIL
LIST
22
PRICE.—The Secretary shall calculate on an annual basis
23
the average retail list price for each drug and biological
24
product sold in Canada, France, Germany, Italy, Japan,
25
and the United Kingdom, through a combination of data
26
VerDate Sep 11 2014
22:45 Apr 21, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\S1218.IS
S1218
kjohnson on DSK79L0C42PROD with BILLS
3
•S 1218 IS
reported by manufacturers of drugs and biological prod-
1
ucts under subsection (e) and data obtained through re-
2
view of publicly filed materials by manufacturers of drugs
3
and biological products in such countries.
4
(d) CIVIL MONETARY PENALTY.—
5
(1) IN GENERAL.—Any manufacturer that vio-
6
lates subsection (b) with respect to a drug or biologi-
7
cal product shall be subject to a civil monetary pen-
8
alty imposed by the Secretary in amount equal to
9
the product obtained by multiplying—
10
(A) the difference between—
11
(i) the list price for the drug or bio-
12
logical product sold in the United States;
13
and
14
(ii) the average retail list price for the
15
drug or biological product sold in Canada,
16
France, Germany, Italy, Japan, and the
17
United Kingdom, as calculated under sub-
18
section (c); and
19
(B) 10.
20
(2) REQUIREMENT.—The amount of a civil
21
monetary penalty under paragraph (1) shall be cal-
22
culated and charged for each unit of drug or biologi-
23
cal product sold.
24
VerDate Sep 11 2014
22:45 Apr 21, 2023
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\S1218.IS
S1218
kjohnson on DSK79L0C42PROD with BILLS
4
•S 1218 IS
(e) DATA COLLECTION.—Each manufacturer of a
1
drug or biological product shall submit to the Secretary
2
on an annual basis—
3
(1) the list price for the drug or biological prod-
4
uct sold in the United States; and
5
(2) the list price for the drug or biological prod-
6
uct sold in each of Canada, France, Germany, Italy,
7
Japan, and the United Kingdom.
8
(f) GUIDANCE AND REGULATIONS.—The Secretary
9
shall issue guidance and promulgate regulations to imple-
10
ment this section.
11
Æ
VerDate Sep 11 2014
22:45 Apr 21, 2023
Jkt 039200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\S1218.IS
S1218
kjohnson on DSK79L0C42PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.